US Patent Issued to Accro Bioscience (HK) on June 30 for "Heteroaryl compounds as inhibitors of RIP2 kinase, composition and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,604, issued on June 30, was assigned to Accro Bioscience (HK) Ltd. (Hong Kong).

"Heteroaryl compounds as inhibitors of RIP2 kinase, composition and application thereof" was invented by Xiaohu Zhang (Suzhou, China) and Sudan He (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides heterocycle compounds with RIP2 kinase inhibitory activity, pharmaceutical compositions comprising the same, methods using the same and applications thereof. The present disclosure provides compounds of Formula (I), as inhibitors of RIP2 kinase. These compounds can be used for preventing and/or treating RIP2 kinase-related diseases an...